Anti-CD45RC Antibody Immunotherapy Prevents and Treats Experimental Autoimmune PolyEndocrinopathy Candidiasis Ectodermal Dystrophy Syndrome

Thursday, June 23, 2022

3:00 PM – 5:00 PM PT

Location: Salons 5/6

Authors: Katharina Wørzner, n/a (Co-Author) - Statens Serum Institut; Judith Ashouri-Sinha, MD (Co-Author) - University of California, San Francisco; Dennis Christensen, n/a (Co-Author) - Statens Serum Institut; Gabriel Pedersen, n/a (Presenting Author) - Statens Serum Institut

Presenter(s)

Carole Guillonneau, PhD

Nantes Université, CHU Nantes, INSERM, Center for Research in Transplantation and Translational Immunology, UMR 1064, F-44000 Nantes, France; LabEx IGO “Immunotherapy, Graft, Oncology”, Nantes, France
Nantes, Pays de la Loire, France

Chair(s)

JV

Jo L. Viney, PhD

Chief Scientific Officer
Pandion Therapeutics
Watertown, Massachusetts, United States